Wholesome Clinic vs Enhance MD
Seven states with the ladder published against thirty-nine on a four-week cycle.
Wholesome Clinic
Editorial
$109/mo
Wholesome Clinic publishes a dose ladder rather than a single figure for each product: compounded semaglutide runs $149 to $199 and above by injection, $109 to $199 as an oral, while compounded tirzepatide runs $349 to $549 by injection and $249 to $349 as an oral. All four are self-pay. The service covers seven states.
Pick it for: Readers inside its seven states who want the climb visible
Enhance MD
Editorial
$184/mo
Enhance MD advertises $212 a month for compounded semaglutide on a twelve-month plan, delivered every four weeks, which is thirteen fills a calendar year and $230 a month. The low-dose tirzepatide plan bills $169 twelve times against a forty-eight-week term, or $184 a calendar month. Labs, the consultation and two-day shipping are described as included, and the semaglutide rate is stated as flat at all doses.
Pick it for: Readers who need wider coverage and can absorb the extra fill
Our verdict
Wholesome Clinic prints every rung but reaches seven states. Enhance MD reaches thirty-nine and bills every four weeks, which is thirteen charges a year. Availability and cadence, not price, decide this one.
What actually separates them
Wholesome Clinic and Enhance MD state different things about published price. Everything else they publish, they publish the same way.
Enhance MD costs $75 more than Wholesome Clinic — 69% more for the same molecule. Whether that buys anything is what the rest of this page is for.
Over twelve months that is about $1,308 at Wholesome Clinic against $2,208 at Enhance MD — a difference of $900.
| Wholesome Clinic | Enhance MD | |
|---|---|---|
| Published price | $109/mo | $184/mo |
Before you choose either
Ask both sellers what dose the monthly price buys before you compare the two figures. A price is only a price once you know what quantity it is attached to, and a seller that will not answer has told you something. Set both against every published price we hold rather than against each other alone.
Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.